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ABSTRACT 
Objectives: Urinary tract infections (UTIs) are one of the most common bacterial infections affecting humans throughout their life span. There is 
paucity of literature in relation to pathogenesis of UTIs caused by Pseudomonas aeruginosa. Therefore the current study was conducted to know the 
antibiotic sensitivity pattern of P. aeruginosa isolated from UTIs from our hospital. 
Methods: The study was carried out over a period of 3 years from January 2010 to December 2012. Urine specimens from both outpatients and 
inpatients of our hospital were processed. Urine samples which yielded the growth of Pseudomonas aeruginosa were included in the study  
Results: Among females, frequency of UTI was more among 21-50 years age groups and among males elderly patients were more commonly 
affected. The most active antimicrobial agent against Pseudomonas aeruginosa isolates were piperacillin-tazobactum (54% sensitive), closely 
followed by Cefoparazone –salbactam (48%). 
Conclusion: This study stresses the importance of prior knowledge of the sensitivity pattern of the pathogen. Treatment should be given only after 
culture and sensitivity has been performed which will prevent the misuse of antibiotics and reduce the development of drug resistance among 
bacteria 
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INTRODUCTION 
Urinary tract infections (UTIs) are one of the most common bacterial 
infections affecting humans throughout their life span. These 
infections are more common in females than in men. Incidence in 
women in the age of 20—40 years ranges from 25 to 30% whereas 
in older women above 60 years of age it ranges from 4 to 43%. [1]  
Pseudomonas aeruginosa is a cosmopolitan gram-negative aerobic 
bacillus isolated from soil, water, plants, and animals, including 
humans. 
MATERIALS AND METHODS  
It is associated with an ever-widening spectrum of 
infections.[2,3] Pseudomonas aeruginosa is an opportunistic 
pathogen, which causes complicated infections mainly of the lower 
respiratory tract, wounds and urinary tract in immunocompromised, 
immunodeficient or surgically manipulated hosts. This organism has 
been reported in 35 per cent cases of catheterized patients of 
complicated UTIs and is difficult to manage. [4] In addition to factors 
involved in the virulence of P. aeruginosa, its resistance to 
antimicrobials contributes to its role as an effective opportunistic 
pathogen. Resistance to antipseudomonal b-lactams has been well 
described, and resistance to recent-generation cephalosporins, 
monobactams, and carbapenems is becoming a disturbing clinical 
problem. [2] There is paucity of literature in relation to pathogenesis of 
UTIs caused by P. aeruginosa. Area-specific monitoring studies aimed to 
gain knowledge about resistance patterns of the isolates may help the 
clinician to choose the right empirical treatment. [1,5] Therefore the 
current study was conducted to know the antibiotic sensitivity pattern of 
P. aeruginosa be isolated from UTIs from our hospital. 
Study population, design, and setting 
The study was carried out in the Department of Microbiology, India over 
a period of 3 years from January 2010 to December 2012. Our hospital 
primarily caters to the semi urban population of Southern India. 
Ethical clearance and consent 
As it was a retrospective study, ethical clearance and consent were 
not obtained. 
Patient evaluation 
Urine specimens from both outpatients and inpatients of our 
hospital having one or more urinary symptoms, like burning during 
micturition, fever, pyuria, frequency of urine, dysuria, hematuria, 
flank pain, suprapubic discomfort, etc., was processed. 
Sample collection, isolation and identification of P. aeruginosa 
Mid-stream urine sample in early morning was collected in wide 
mouth sterile container.[6]All urine samples were examined by 
routine microscopic examination by wet mount of urine. 
Simultaneously all urine samples were cultured over routine culture 
media; Cysteine lactose electrolyte deficient (CLED) agar with a 
sterile standard loop. These plates were incubated at 37°C for 24 
hours. Culture results were interpreted according to the standard 
criteria and a growth of ≥10  5 colony forming units/ml was 
considered as significant bacteriuria.[7]cultures with more than 
three colonies were discarded, as contaminants and their antibiotic 
susceptibility were not tested. P. aeruginosa were identified by 
conventional biochemical tests according to standard 
microbiological techniques. [6]
Antimicrobial susceptibility testing 
  
All isolates of P. aeruginosa were tested for antimicrobial 
susceptibility on Mueller Hinton agar by the standard disc diffusion 
method recommended by the Clinical and Laboratory Standards 
Institute (CLSI). [8] 
Statistical analysis 
Antimicrobial agents (disks) were obtained from 
Hi Media laboratories, Pvt Ltd, Mumbai. Appropriate quality control 
strains were used to validate the results of the antimicrobial disk. E. 
coli, ATCC 25922, and Pseudomonas aeruginosa, ATCC 27853, were 
used as quality control strains. [8] 
Statistical analysis was performed with SPSS 14 software. 
Continuous data were summarized as mean and categorical data 
was summarized as percentage. Chi square test was applied for 
analysis of categorical data. P value < 0.05 was taken as significant 
for interpretation.  
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RESULTS 
The most active antimicrobial agent against Pseudomonas 
aeruginosa isolates (Table 2) were piperacillin-tazobactum (54% 
sensitive), closely followed by Cefoparazone –salbactam (48%). 
Amikacin was more effective aminoglycoside than others.  
Least active antibiotics were Amoxyclav (6%) and Netilmicin.(18%). 
 
Table 1: Age wise distribution of Pseudomonas aeruginosa isolates from UTI patients. 
Age in years Total(n=81) 
 Number Percentage 
1-20 2 2.4 
21-50 43 53.1 
> 51 36 44.4 
Among females, frequency of UTI was more among 21-50 years age group and among males elderly patients were more commonly affected. (Table 1) 
 
Table 2: Antimicrobial susceptibility of uropathogenic Pseudomonas aeruginosa isolates. 
Antibiotics Sensitive Sensitive(%) 
Gentamicin 27 33.3 
Ciprofloxacin 22 27.2 
Norfloxacin 21 25.9 
Carbenicillin  17 20.9 
Amoxyclav 05 6.17 
Amikacin 35 43.2 
Cefoparazone –salbactam 39 48.1 
Piperacillin-tazobactum 44 54.3 
Ofloxacin 26 32.1 
Netilmicin 15 18.5 
Imipenem  30 37 
 
Table 3: The prevalence of multi-resistance of Pseudomonas aeruginosa isolates from UTI patients 







Seventy eight (97%) of all the isolates (Table 3) were multi-drug resistant. Multi-drug resistance in this study was defined as resistance of an isolate 
to at least one antimicrobial agent in at least three classes of antimicrobial agents tested. 
 
 
Graph 1: Antimicrobial susceptibility of uropathogenic 
Pseudomonas aeruginosa isolates. 
 
DISCUSSION 
UTI represents one of the most common diseases encountered in 
medical practice, causing significant associated morbidity and 
occurring from neonate to the elderly. Studies have demonstrated 
geographic variation in etiologic characteristics of UTI and their 
resistance patterns to antibiotics. Therefore to successfully eradicate 
UTI by empiric treatment, knowledge of local etiologic agents and 
their antibiotic susceptibility is of great value. [9-11]
Among females, frequency of UTI was more among 21-50 years age 
group. Among sexually active young women the incidence of 
symptomatic UTI is high, and the risk is strongly associated with 
recent sexual intercourse, recent use of diaphragm with spermicide, 
and a history of recurrent UTI. [12]
  
 
Pseudomonas aeruginosa is intrinsically resistant to several classes 
of antibiotics, thus limiting therapeutic options. Unfortunately, 
antimicrobial therapy is becoming even more problematic due to 
acquired or mutational resistance. A wide range of resistance 
mechanisms have been identified including multi-drug efflux pumps 
(which can confer resistance to, among others, cephalosporins 
ureidopenicillins, fluoroquinolones and aminoglycosides), 
aminoglycoside-modifying enzymes, b-lactamases, and target site 
modifications. Resistance to a particular class may be mediated by 
several mechanisms. For example, isolates may lose susceptibility to 
a carbapenem due to production of a carbapenemase, loss of the 
OprD porin, or via a multidrug efflux pump. Souli et al. Recently 
published data from 23 countries on the European Antimicrobial 
Resistance Surveillance System website. Resistance rates for 
aminoglycosides, carbapenems, quinolones and ceftazidime were 0-
51.9%; 9-50.5%; 7.2-51.9% and 4-48.5%, respectively. [13, 14]
Among males frequency of UTI 
was more in people of more than 50 years, elderly patients were 
more commonly affected This is probably because with advancing 
age, the incidence of UTI increases among males due to prostate 
enlargement and neurogenic bladder. [13]  
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In our study resistance rates were slightly higher when compared 
with above study. It is remarkable that there are considerable 
differences among isolates in different geographic regions. The 
reasons for these differences in antimicrobial susceptibility are 
generally unclear but may be due to differences in antimicrobial 
utilization practices and the quality of infection control practices or 
public health infrastructures. [2]  
Perhaps the most concerning development in recent years has been 
the emergence of carbapenemases in MDR strains of P. aeruginosa. 
Loss of the carbapenems, which have been the mainstay of therapy 
for infections caused by MDR strains, severely limits therapeutic 
options. [3] In our study also the rare of resistance to imipenem was 
high (67%)  
Majority of the isolates were from hospitalized patients this can be 
explained by the following reasons. Several properties of P. 
aeruginosa favor persistence in the hospital environment. The 
bacterium is inherently resistant to several disinfectants such as 
biguanides and quaternary ammonium compounds through the 
action of multidrug efflux pumps. Furthermore, the ability to form 
biofilm on a range of inanimate surfaces also contributes to 
disinfectant resistance as well as impeding physical 
removal.[3,15]Similar results have been reported by other 
investigators. [16,17] 
CONCLUSION 
Given the potential severity of specific P. aeruginosa infections and 
problems in selecting optimal therapy for multidrug resistant (MDR) 
isolates, identification and implementation of effective strategies to 
prevent these infections are urgent priorities. [3] 
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It is a matter of 
great concern that, majority of the isolates included in this study 
were found resistant to three or more antibiotics. Therefore 
treatment should be given only after culture and sensitivity have 
been performed which will prevent the misuse of antibiotics and 
reduce the development of drug resistance among bacteria. 
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